Preprint · CC-BY
via OpenAlex
Muscle hypertrophy driven by myostatin blockade does not require stem/precursor-cell activity
Helge Amthor, Anthony Otto, Adeline Vulin, Anne F. Rochat, Julie Dumonceaux, Luis Alberto Garcia, Étienne Mouisel, Christophe Hourdé, Raymond Macharia, Melanie Friedrichs, Frédéric Relaix, Peter S. Zammit, Antonios Matsakas, Ketan J. Patel, Terence A. Partridge
Proceedings of the National Academy of Sciences · 2009 · ▲ 198 citations
Abstract
Myostatin, a member of the TGF-beta family, has been identified as a powerful inhibitor of muscle growth. Absence or blockade of myostatin induces massive skeletal muscle hypertrophy that is widely attributed to proliferation of the population of muscle fiber-associated satellite cells that have been identified as the principle source of new muscle tissue during growth and regeneration. Postnatal blockade of myostatin has been proposed as a basis for therapeutic strategies to combat muscle loss in genetic and acquired myopathies. But this approach, according to the accepted mechanism, would raise the threat of premature exhaustion of the pool of satellite cells and eventual failure of muscle regeneration. Here, we show that hypertrophy in the absence of myostatin involves little or no input from satellite cells. Hypertrophic fibers contain no more myonuclei or satellite cells and myostatin had no significant effect on satellite cell proliferation in vitro, while expression of myostatin receptors dropped to the limits of detectability in postnatal satellite cells. Moreover, hypertrophy of dystrophic muscle arising from myostatin blockade was achieved without any apparent enhancement of contribution of myonuclei from satellite cells. These findings contradict the accepted model of myostatin-based control of size of postnatal muscle and reorient fundamental investigations away from the mechanisms that control satellite cell proliferation and toward those that increase myonuclear domain, by modulating synthesis and turnover of structural muscle fiber proteins. It predicts too that any benefits of myostatin blockade in chronic myopathies are unlikely to impose any extra stress on the satellite cells.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1073/pnas.0811129106
- Canonical
- link ↗
- Fetched
- 2026-09-30 MST
Cite this
APA
Amthor, H., Otto, A., Vulin, A., Rochat, A.F., Dumonceaux, J., Garcia, L.A., Mouisel, �., Hourdé, C., Macharia, R., Friedrichs, M., Relaix, F., Zammit, P.S., Matsakas, A., Patel, K.J., & Partridge, T.A. (2009). Muscle hypertrophy driven by myostatin blockade does not require stem/precursor-cell activity. <em>Proceedings of the National Academy of Sciences</em>. https://doi.org/10.1073/pnas.0811129106
Vancouver
Amthor H, Otto A, Vulin A, Rochat AF, Dumonceaux J, Garcia LA, et al. Muscle hypertrophy driven by myostatin blockade does not require stem/precursor-cell activity. Proceedings of the National Academy of Sciences. 2009. doi:10.1073/pnas.0811129106.
BibTeX
@unpublished{helge2009Muscle,
title = {Muscle hypertrophy driven by myostatin blockade does not require stem/precursor-cell activity},
author = {Helge Amthor and Anthony Otto and Adeline Vulin and Anne F. Rochat and Julie Dumonceaux and Luis Alberto Garcia and Étienne Mouisel and Christophe Hourdé and Raymond Macharia and Melanie Friedrichs and Frédéric Relaix and Peter S. Zammit and Antonios Matsakas and Ketan J. Patel and Terence A. Partridge},
journal = {Proceedings of the National Academy of Sciences},
year = {2009},
doi = {10.1073/pnas.0811129106},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Journal of Cellular Physiology 2006
Citation only
Prolonged absence of myostatin reduces sarcopenia
Current Biology 2018
Open access · OA
Muscle stem cells
Nutrition & Metabolism 2021
Open access · CC-BY
Disease-associated metabolic alterations that impact satellite cells and muscle regeneration: perspectives and therapeutic outlook
Current topics in developmental biology/Current Topics in Developmental Biology 2017
Citation only
Muscle Stem Cells and Aging
Ageing research reviews 2026
Citation only
Ageing of the skeletal muscle as a barrier to cell therapy: Cell sources, microenvironmental failure and autologous alternatives.
Nature Communications 2017
Open access · CC-BY